Ponatinib (AP24534) , ≥99% , 943319-70-8
CAS NO.:943319-70-8
Empirical Formula: C29H27F3N6O
Molecular Weight: 532.56
MDL number: MFCD17215203
EINECS: 1308068-626-2
Pack Size | Price | Stock | Quantity |
10MG | RMB332.80 | In Stock |
|
50MG | RMB1011.20 | In Stock |
|
250MG | RMB2492.80 | In Stock |
|
others | Enquire |
PRODUCT Properties
Melting point: | >175°C (dec.) |
Density | 1.3 |
storage temp. | -20°C |
solubility | Soluble in DMSO (up to 50 mg/ml) or in Ethanol (up to 25 mg/ml with warming). |
form | Yellow powder. |
pka | 12.99±0.70(Predicted) |
color | Yellow |
Stability: | Stable for 2 years from date? of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 3 months. |
CAS DataBase Reference | 943319-70-8 |
Description and Uses
Ponatinib (943319-70-8) is a highly potent pan-Bcr-Abl and multikinase inhibitor, suppressing the activity of native Bcr-Abl (IC50=0.37 nM) as well as the mutants T315I (IC50=2 nM), Q252H (IC50=0.44 nM), Y253F (IC50=0.3 nM), M351T (IC50=0.3 nM) and H396P (IC50=0.34 nM).1??Also inhibits PDGFRα, c-Src and c-Kit (IC50=1.1, 5.4 and 12.5 nM respectively)2?as well as FGFR-mediated signaling (IC50<40 nM)3. Protects against influenza A virus-induced death by suppressing cytokine storm in mouse models..4
AP24534 is a novel potent, orally available small molecule multitargeted kinase inhibitor with IC50 of 0.37, 2, 1.5, 2.2, 1.1, 1and 0.24 nM for native pan-BCR-ABL, mutated form, VEGFR2, FGFR1, PDGFRα, mutant FLT3 phosphorylation and LYN.
Safety
Symbol(GHS) | GHS06,GHS08 |
Signal word | Danger |
Hazard statements | H301+H311+H331-H361d-H372 |
Precautionary statements | P260-P280-P301+P310 |
HS Code | 29335990 |
Hazardous Substances Data | 943319-70-8(Hazardous Substances Data) |